Health Archive » September, 2025

Health - September, 2025

371 articles

• McKinsey Trims Endo Suit But Can't Nix Indemnification Claim
• Feds Finalize Rules To Speed H-2A Filing, Limit Some Wages
• Ill. Doctor Gets Two Years' Probation For $4M Medicare Fraud
• Texas Court Upends $13M Home Care Car-Train Crash Verdict
• Pharmacist Gets 35 Months For 'Insidious' $11M Drug Scheme
• Blue Cross Insurers Sanctioned For 2-Year Discovery Drawout
• Nevada Hospital Nets $510M Verdict In Staff Poaching Suit
• HHS Moves To Suspend Harvard From Funding
• Judge Ends Challenge To Mich. Abortion Rights Amendment
• Wis. Legislators Trying Again To Legalize Medical Cannabis
• Judge Freezes Chinese Cos.' Assets In X-Ray IP Suit
• Hospital Urges Justices To Review 7th Circ. Medicaid Ruling
• Health Aide's Overtime Case Ends After Settlement Rewrite
• FCA Suit Tainted By Expert's AI 'Hallucination' Gets Dismissed
• Ga. Panel Won't Nix $4M Verdict In Toddler Death Suit
• Junior Attys Must Beware Of 5 Common Legal Brief Mistakes
• Pfizer Says Drugmaker Moving Too Early On Arthritis Generic
• Trulieve Says Berkshire Hathaway Must Defend Death Suit
• CTA Could Face Second Ill. Jury Over Vaccine Bias Allegations
• 6 Copyright, TM Cases On Tap As Justices Begin New Term
• House GOP Lawmakers Back ITC Import Ban Won By Oura
• No New Trial In Eyedrop TM Case, But Damages Cut To $11M
• Ill. Judge Trims Suit Over Chicago Children's Hospital Hack
• Terumo Secures $5M Cost Award After Beating Cancer Claims
• Benefits Co. Can't Escape Worker's Tobacco Surcharge Suit
• 11th Circ. Backs Somatics' Win In Man's Brain Damage Suit
• TikTok Can't Use Section 230 To End NJ AG's Harm Suit
• Mass. Appellate Court Revives Hospital Worker's Vaccine Suit
• Assessing Legal, Regulatory Hurdles Of Healthcare Offshoring
• Idaho Pushes Back On Effort To Moot Trans Athlete Ban Case
• Yale Unit Will Pay $45M To End Failed Hospitals Sale Dispute
• Therapist Admits Sending Patient's Funds To Scammers
• Meta Set To Appeal Flo Privacy Verdict As Users Seek Billions
• EssilorLuxottica Beats Antitrust Suit, Buyers Get 1 Last Shot
• States Sue HHS For Order Erasing Gender Ideology In Sex Ed
• Semler Scientific, Bard To Pay $37M To End FCA Claims
• Judge Criticizes Push For Harsher Sentence In CytoDyn Case
• Inotiv Inks $8.75M Investor Deal Over Animal Welfare Claims
• Conn. Psych Facility Faces Class Claims Over Data Breach
• Illumina And Grail Nix Investor Suit Over Failed Deal, For Now
• Clinic Defends Legal Malpractice Suit Over Ex-Eagle's Case
• Pa. Cannabis Patient Says Job Offer Withdrawn Over Drug Test
• Mich. High Court To Revisit Wrongful Death Tolling Rule
• Woman Left Blind, Paralyzed After Stroke Awarded $70.8M
• High Court Pauses Distribution Of $4B Foreign Aid
• Texas High Court Won't Redo Med Mal Nonprofit Liability Case
• Lessons As Joint Employer Suits Shift From Rare To Routine
• Trump Announces 100% Tariff On Drug Imports Starting Oct. 1
• Taxation With Representation: De Brauw, Hengeler Mueller
• Commerce Opens 2 New Section 232 Investigations
• 7 Firms Build GTCR's CA$3.3B Dentalcorp Take-Private
• UK Litigation Roundup: Here's What You Missed In London
• Texas Suit Marks Renewed Focus On Service Kickback Theory
• Power To The Paralegals: How And Why Training Must Evolve
• Senate Dems Float Bill To Shield Neural Data From Misuse
• $8.9B Deal For Health Tech R1 RCM Draws Del. Chancery Suit
• COVID-19 Orders Could Save Embryo Loss Case, Court Hears
• GAO Says Agencies' Procurement Data Reports Are Lacking
• Perrigo Mostly Beats US In $163M Tax Refund Dispute
• GE Avoids Retirees' Lawsuit Over Pension Annuity Deal
• MiMedx, FDA Ordered To Rework Args In Wound Care Case
• Pa. High Court Backs Two-Lab Rule For Medical Pot Products
• Sens. Renew Bipartisan Push To Fund Schools On Federal Lands
• AstraZeneca Asks High Court To 'Unscramble' Drug Price Law
• TM Dispute Over DIY Dentures Dismissed In NC
• Oracle, Meta Mull $20B AI Deal, As Tech Rumors Abound
• Labcorp Workers Balk At Paying For Expert's Biz Class Airfare
• Playing Softball Makes Me A Better Lawyer
• 5 Years In, COVID-19 Fraud Enforcement Landscape Is Shifting
• Depo-Provera MDL Plaintiff Numbers Balloon To 1,300
• Aetna Can't Rein In LGBTQ+ Bias Suit Over Fertility Coverage
• Families Cite Trump In Bid To Revive Tylenol Autism Claims
• Conn. Cities' Insulin Pricing Suits Against PBMs Join NJ MDL
• Second 'Drugs Made In America' SPAC Raises $500M In IPO
• DC Judge Won't Reinstate IGs Over 'Obvious' Trump Violation
• Ga. Panel Reverses Early Win In Ambulance-Mower Crash
• UnitedHealth Fights Investor Suit Over DOJ's Merger Probe
• Google, Flo To Pay Combined $56M To End Data Privacy Suit
• Pharmacies Labeled As Gatekeepers In Fla. Opioid Trial
• Planned Parenthood Shooter Still Not Competent For Trial
• CVS Moves To End Worker's Tobacco Surcharge ERISA Suit
• Court Sides With Texas, Nixes Medicaid Tax Funding Rule
• Omnicare Can Tap $25M Initial DIP, Stage Set For Gov't Feud
• Minn. Justices Reject Humana's Pharmacy Sourcing Appeal
• Vanda Ruling Opens Door For Contesting FDA Drug Denials
• Committee Says $100M DIP Loan Doesn't Benefit Modivcare
• NC Med. Provider Exposed 450K Peoples' Data, Patient Says
• Trans Youth Care Ban Discriminatory, Mo. High Court Hears
• Medical Marijuana Operators Claim Okla. Undermines Industry
• 4th Circ. Kicks Trans Care Exclusion Suits Back To Trial Court
• DOJ Likely Crossed Line With Mangione Remarks, Judge Says
• Helicopter Cos. Say Aetna 'Grasping At Straws' In $20M Fight
• Let States Use Leftover BEAD Funds, Sen. Wicker Says
• HHS Allocates $1.5B To States, Tribes To Combat Opioid Crisis
• States Say Ed Dept. Must Face Suit Over Mental Health Cuts
• Law School's Missed Lessons: Mastering Time Management
• Mich. Hospital Must Bargain With SEIU Amid 6th Circ. Appeal
• Courts Keep Upping Standing Ante In ERISA Healthcare Suits
• UC Researchers Win Expanded Injunction Against Grant Cuts
• Eli Lilly Deal In Weight Loss Drugs Trademark Suit Hits Snag
• Google, Meta Beat BlueChew Users' Privacy Suit, For Now
• This Week In Healthcare Cybersecurity
• Axsome Settles Investors' Drug Approval Suit For $7.8M
• DHS Floats H-1B Rule To Prioritize Higher-Paid Workers
• 9th Circ. Won't Revive Religious Bias Suit Over COVID Tests
• Tylenol MDL In Spotlight After Trump Blasts Use In Pregnancy
• How Attys Are Riding The Mass. Biotech 'Roller Coaster'
• Mich. Doctor Gets 6 Years For Role In Opioid Pill Mill
• NC Sens. Vote To Cut Planned Parenthood's Medicaid Funds
• DC Circ. Scraps OK Of $8.7M Equatorial Guinea Hospital Award
• Calif. Bill May Shake Up Healthcare Investment Landscape
• Ch. 11 Shields Co. From Suit Over Inmate Stroke, Judge Says
• Dentists Denied Class Certification In $13B Delta Dental Suit
• Social Media Giants Must Face Expert Testimony On Harm
• EX-CTA Worker's $425K Vaccine Bias Award Capped At $300K
• Two Longtime HHS Attys Depart Posts For Crowell & Moring
• Burns White Launches Correctional Healthcare Practice Group
• Foley & Lardner Adds Healthcare Deals Pro From Holland & Knight
• HealthTrackRx Names 2nd Chief Legal Officer In 2025
• How Hyperlinks Are Changing E-Discovery Responsibilities
• AI Health Benefits Platform Secures $400M In New Funding
• Pa. Health Network To Pay $1.15M In 401(k) Forfeiture Suit
• 2nd Circ. Undoes $25M Restitution In Horse-Doping Case
• Family Sues For $100M In Child's Hyperbaric Chamber Death
• 5th Circ.'s 340B Ruling 'Limited,' Pharma Cos. Tell 4th Circ.
• J&J Ruling Misapplied Goldman Precedent, 3rd Circ. Told
• Harvard Beats Suit Over Instructor's Vaccine-Refusal Firing
• Pharma Copay Programs Raise Complex Economic Questions
• State False Claims Acts Can Help Curb Opioid Fund Fraud
• Mich. Judge Won't Certify Class In Dental Insurer TCPA Suit
• CVS's Omnicare Hits Ch. 11 After $949M FCA Judgment
• Novant Escapes Black Ex-Lab Worker's Race Bias Suit
• Wachtell, Paul Weiss Advise On Pfizer's $7.3B Obesity Path
• Fla. Marketer Gets 57 Months For $11.5M Medicare Fraud
• Anthem's $12.9M ERISA Deal Clears First Hurdle
• Mayo Clinic Can't Fully Nix Suit Over Withheld Benefits Info
• 4 Firms Build Patient Square's $2.6B Premier Take-Private Deal
• ProPhase COVID-19 Testing Units Hit Ch. 11 In NJ
• Trump Tags H-1B Visa Apps With $100,000 Fee
• IBS Drug Buyers Win Class Cert. In Takeda Antitrust Case
• Ga. Providers Seek Exit From 'Conspiratorial' BCBS Fraud Suit
• Goodwin, Latham Steer E-Commerce Co. Pattern's $300M IPO
• Fla. Court OKs $20M Settlement In Fortra Data Breach MDL
• Surgery Center Wins Contract Fight With Spine Doc
• 11th Circ. Backs Insurer In Damaged Blood Plasma Suit
• 'Occurrence' Lessons From Policyholder's COVID Ruling Win
• Polsinelli Adds ArentFox Schiff Bankruptcy Pro In NY
• Rite Aid Gets OK To Seek Votes On Dual-Track Ch. 11 Plan
• CDC Panel Urges Caution On COVID Vax, Punts On Hep B
• Prospect Medical Says It May Drop Stay On Tort Cases
• Ill. Justices Reverse Therapist's Fee Win Against Regulator
• Federal Vaccine Panel Votes To Tweak MMRV Recommendation
• Brothers Blame Associate For $90M HIV Drug Fraud Scheme
• Mich. Top Court To Weigh Medicare's Role In No-Fault Cases
• HHS Shutters Miami Organ Donor Org. For 'Unsafe' Practices
• Elevance Won't Cover Zepbound To Treat Apnea, Patient Says
• Feds Launch 'First Wave' Of Housing Fraud Cases In Minn.
• Senate Confirms Trump's Pick To Lead DOL Benefits Arm
• Medical Staffing Co. Trustee Says Ex-Execs Drained Funds
• Couple Slam NC Defense Attys In Hospital Negligence Appeal
• Steptoe Adds Jones Day Biotech Patent Pro To NY Office
• 1st Circ. Won't Lift Block On HHS Job, Program Cuts
• Uber Says Philly Law Firm, Doctors Fabricated Injuries
• NJ City Makes 3rd Escape From Pot Co.'s Zoning Suit
• Michigan Pushes Appeals Court To Reinstate Abortion Laws
• Writing Musicals Makes Me A Better Lawyer
• J&J Whistleblowers Defend $1.6B False Claims Act Win
• Judge Probes Alleged Rivalry In Captive Insurer's Collapse
• 9th Circ. Denies Appeal Of Wash. Anti-Vaxxers' Med Board Suit
• 3rd Circ. Weighs Limits On NJ Medical Aid In Dying Act
• Missouri AG Can Seek Unredacted Trans Care Records
• Hospital Agrees To End Retirement Plan Fee, Investment Suit
• GAO Sustains Protest Of $48.5M Medicare Contract
• Cardinal Health Legal Chief Sees $4.9M In 2025 Pay
• Ex-CDC Head Says RFK Jr. Urged Vax Schedule Rubber Stamp
• Purdue Can Pay CEO Ch. 11 Bonus After Trimming Comp
• Ex-Pharmacy Tech Gets 20 Mos. For $5M Drug Scheme
• 4th Circ. Won't Revisit $9M Nurse Misclassification Ruling
• Yale Health System Settles $435M Hospital Sale Suit
• Adapting To Private Practice: From Va. AUSA To Mid-Law
• Dr.'s COVID Falsehoods Are Free Speech, Wash. Panel Says
• Harborview Nurses In Ga. Score Collective Status In OT Suit
• UC Groups Sue Trump Admin Alleging Free Speech Violations
• Merck Says Vaccine Case 'Poor Vehicle' For Antitrust Review
• Meta Loses Bid To Overturn Verdict In Flo Privacy Class Action
• Miami Hospital's Ex-COO Admits To Embezzling $4.3M
• FTC Ends Director Overlap In Healthcare Space
• Okla. Tribe Sues Social Platforms Over Youth Mental Health
• BrainStorm Can't Shed Investors' ALS Treatment Trial Claims
• Tax-Exempt Hospitals Face Financial Duress, Panel Hears
• Wash. Justices Scrutinize Minimum Wage 'Live In' Exclusion
• Ill. Hospital Nonprofit Must Face Tobacco Fee Suit
• DC Circ. Asked To Look At ADA Injunction In Segregation Case
• Transmission Security Has A Critical Role In Healthcare
• Doximity Says AI Startup Using Lawsuits To Thwart Rivals
• CVS Caremark Takes $290M Overbilling Judgment To 3rd Circ.
• FTC Chair Pledges 'Action' Against Late Merger Fixes
• Rebutting Price Impact In Securities Class Actions
• Jones Day Adds FDA Regulatory Expert As Of Counsel In DC
• 7 Document Review Concepts New Attorneys Need To Know
• For Cahill Atty, Rare Disease Pro Bono Work Is Personal
• FTC Actions Highlight New Noncompete Enforcement Strategy
• HHS OIG Senior Counsel Joins Polsinelli As Shareholder
• Ruling On Labor Peace Law Marks Shift For Cannabis Cos.
• Deference Ruling Could Close The FAR Loophole
• Top 2 Counts Dismissed Against Luigi Mangione
• W.Va., Idaho Tell Justices Trans Sports Bans Based On Science
• Ch. 11 Plan Faces Blowback From 23andMe Breach Claimants
• Social Media Apps Can't Toss Mental Health Suit In Mass Tort
• Mich. Says HHS Can't Justify $195M Medicaid Clawback
• Investor Says $16M Ouraring Fight Shouldn't Go To Finland
• Stewart Says New Policies Seek Fairness For Patent Owners
• Surgical Center, Surgeon Clash Over $75K Settlement At Trial
• Eli Lilly Fights $278M Drug Royalties Ruling At 9th Circ.
• Corcept Can't Escape Teva's Mifepristone Antitrust Suit
• Mich. Ordered To Clarify Stance On Clinic's Trans Care Policy
• Med Transport Co. Founder Sues In Del. Over Share Cash-Out
• Hill-Rom Escapes Pennsylvania Hospital's Monopoly Claims
• Novartis, Monte Rosa Ink Up To $5.7B 'Molecular Glue' Deal
• Ex-Investor Relations Exec Gets 15 Months For Inside Trades
• AbbVie Can't Halt Miss. Discount Drug Law, 5th Circ. Says
• 23AndMe Inks $3.25M Data Breach Deal With Canadian Users
• Jury Awards Mallinckrodt $9.5M In Nitric Oxide Patent Suit
• Anti-Vax Dr. Asks 11th Circ. To Revive NYT Defamation Suit
• Bill Aims To Secure Advance Funding For Tribal Services
• Agentic AI Puts A New Twist On Attorney Ethics Obligations
• Ex-Conn. Assistant AG Faces DQ Bid In Price-Fixing Case
• When AI Denies, Insurance Bad Faith Claims May Follow
• UK Litigation Roundup: Here's What You Missed In London
• Fresh Angles On Display In ERISA Summer Filing Uptick
• States Push Conn. Court To Ban Generic Drug Price-Fixing
• 9th Circ. Says News Article Doesn't Doom Biotronik FCA Suit
• Medicare Drug Pricing Plan Survives Novartis' 3rd Circ. Appeal
• 2 NY Fertility Clinics Must Face Suit Over Destroyed Eggs
• Doctor Says Brother's Ex-Firm Reneged On Pro Bono Promise
• Expert's AI Hallucinations Blamed On Attys' 'Willful Blindness'
• 1st Circ. OKs Freeze Of Planned Parenthood Medicaid Funding
• Insulin Makers Ask 2nd Circ. To Rethink Collusion Claims
• 7th Circ. Backs $183M FCA Award Over Eli Lilly Drug Rebates
• Health Insurance Kickback Cases Signal Greater Gov't Focus
• LifePoint Must Face Workers' 401(k) Mismanagement Suit
• Freshfields, Kirkland Advise On Advent's $4.7B Zentiva Sale
• FDA Transparency Plans Raise Investor Disclosure Red Flags
• Yale New Haven Offers $18M To Settle Data Breach Claims
• Fla. Doc Can Pursue Defamation Claims Against CNN, Cooper
• Being A Professional Wrestler Makes Me A Better Lawyer
• 5th Circ. Won't Revisit Doctor's Captive Insurance Case
• Feds Barred From Axing 30-Year Noncitizen Services, For Now
• FTC Urged To Probe Microsoft Over Ascension Data Breach
• Pa. Court Upholds Defense Verdict In Throat Surgery Suit
• NJ Comptroller Targets Firm Linked To Exonerated Mogul
• Ga. Stroke Patient Seeks New Trial Over Misdiagnosis Claims
• Teleradiology Co. Seeks OK Of Award Nixing $2M Fraud Claim
• Texas Panel Says Expert Not Qualified In Facelift Suit
• FTC Warns Healthcare Employers About Noncompetes
• Colo. Gov. Urges Extension Of Fed. Enhanced Premium Credit
• $36M DOL Award Unjustified, Nursing Homes Tell 3rd Circ.
• Medical Equipment Co. Settles County Claims In Opioid MDL
• Jones Day Adds Ex Fed. Prosecutor To SF Healthcare Team
• Law School's Missed Lessons: Adapting To The Age Of AI
• Holland & Knight Adds King & Spalding Health Ace In Houston
• Ch. 11 Ruling Voiding $2M Litigation Funding Sends A Warning
• 4th Circ. Debates Whether 'Silence' In 340B Empowers States
• CVS Says Takeda Tried To Block Heartburn Drug Competition
• Trump Admin Blocked From Boston Hospital Trans Care Docs
• Colo. Justices Rule Interest Not Covered By $1M Med Mal Cap
• Head Start Immigration Checks May Be Paused, Judge Hints
• Pa. Panel Won't Nix Hospice Co. COVID Infection Suit
• Zantac Buyers Will Appeal Sanofi Dismissal From Conn. Suit
• Omni Must Pay Atty Fees Over 'Troubling' Conduct In FCA Suit
• MAHA Report Calls For Increased Scrutiny Of Drug Advertising
• Nursing Exec Says $10.5M Fraud Penalty Excessive
• No CGL Coverage In Medical Negligence Row, NM Court Says
• Particle's Antitrust Battle With Epic: 3 Things To Know
• UFCW Fund Accuses NYC Hospital Giant Of Juicing Prices
• DOJ's Novel Cybersecurity FCA Case Is A Warning To Medtech
• Full 11th Circ. Backs Health Plan's Gender Care Exclusions
• Roberts Pauses Foreign Aid Distribution For Now
• Lambda Legal Attorney Indicted Over Judge Shopping Probe
• Kidney Care Co. Strive Health Secures $550M In New Funding
• DOJ, FTC Urged To Probe Drugmakers' Rebate Models
• Demystifying The Civil Procedure Rules Amendment Process
• Split 4th Circ. Axes States' Challenge To Trump Admin Layoffs
• Walgreens Fired Pharmacy Heads After Union Vote, Suits Say
• NY AG To Fight Texas Bid To Enforce Abortion Ban Ruling
• Mayo Clinic Beats Suit Over Fatal Brain Hemorrhage
• Oura Domestic Labor Investment Won Import Ban, ITC Says
• Lowe's Workers Drop Suit Claiming Unlawful Insurance Fees
• FisherBroyles Can't Nix Stem Cell Patent Malpractice Claim
• Court Tosses Benefits Co.'s Atty Fee Claim Against Insurer
• Trump Returns To High Court In Foreign Aid Freeze Dispute
• FibroGen To Pay SEC $1.25M Over Drug Mistatements
• With Obligor Ruling, Ohio Justices Calm Lending Waters
• 23andMe's Ch. 11 Sale Flouted State Privacy Law, Calif. Says
• DC Circ. Won't Halt Order Releasing Billions In Foreign Aid
• Stewart Tackles Markets, Injunctions In Newest PTAB Reviews
• Judge Doubts DOE Stance On Ending Mental Health Grants
• DOJ Pushes To DQ Attorney Over Conflict In Fraud Case
• Merck Shakes Off Some Claims From Cholesterol Drugs Suit
• HCA Healthcare Can't Halt Discovery In 401(k) Forfeiture Suit
• Vein Tech Maker Wants Suit Over DOJ Kickback Probe Tossed
• FDA Explains Rejection Of MDMA Therapy For Treating PTSD
• Casper Can't Escape Innovator-Liability Drug Label Suit
• Ga. Ban On Trans Prisoner Healthcare Paused, Class Certified
• Integra Wound Dressing Disfigured Woman's Foot, Suit Says
• 6th Circ. Finds Boss' Pregnancy Remark Supports Bias Claim
• Brown Univ. Prof Says Top Court Ruling Bolsters Habeas Bid
• Mass. Justices Mull Privacy Issues In Era Of Online Records
• How 2nd Circ. Cannabis Ruling Upends NY Licensing
• Motley Rice Fights OptumRx DQ Bid In Utah Opioid Suit
• Court Denies Vape Interests' Bid To Halt Wisconsin E-Cig Law
• Workers Say Tenet Misspent Forfeitures In Mega 401(k) Plan
• CEO's Alleged Threat After Records Demand Prompts Del. Suit
• GRSM Launches Practice For Correctional Healthcare
• Taxation With Representation: Milbank, Wachtell, Latham
• Parenting Skills That Can Help Lawyers Thrive Professionally
• Feds Seek Stay On Court Order Releasing Foreign Aid Billions
• Split 3rd Circ. Rejects Janssen, Bristol Myers Pricing Appeal
• Doc Tells 1st Circ. Acquitted Conduct Marred Drug Sentence
• 10th Circ. Ends Huffing Death Product Liability Suit
• Feds Stand By $10M Medicare Fraud Conviction At 4th Circ.
• Yale Hospital's Info Request Upheld In $435M Property Suit
• 4th Circ. Affirms Gardasil's Vaccine Table Inclusion
• Admonished For 'Entitlement,' Pillsbury Atty Ducks Sanction
• Why The Harvard Funding Case Is 'Clear As Mud' On Appeal
• Aetna, Optum's $8.3M ERISA Health Fee Deal Gets Final OK
• DOJ Moves To End Challenge To RFK Jr.'s Vaccine Directive
• Monthly Merger Review Snapshot
• DC Circ. Probes NLRB's 'Successor' Bar After Loper Remand
• PBMs Look To Toss FTC's Insulin Pricing Case
• RFK Renews Attacks On CDC At Fiery Capitol Hill Appearance
• 3rd Circ. Preview: Sept. Features Biosimilars, Gambling Cases
• Top NIH Scientists Allege Retaliation For Defending Vaccines
• Teaching Trial Advocacy Makes Us Better Lawyers
• Life Insurer Accused Of Policy Rescission Scheme
• Unions Defend Challenge To Federal Work Safety Agency Cuts
• PBM Rule Included In DOL Benefits Arm's Regulatory Update
• Purdue Pharma Approved For $17.5M In Ch. 11 Bonus Plans
• Ohio Cannabis Card Network Sued Over Faulty Cybersecurity
• 9th Circ. Affirms Toss Of Satanists' Idaho Abortion Ban Suit
• How Morgan & Morgan Got Ousted As Top Federal Tort Filer
• Atty's 'Highly Prejudicial Falsehood' Sparks Med Mal Retrial
• Insurance Firm Adds Texas Office As Claim Denials Spike
• Federal AI Action Plan Marks A Shift For Health And Bio Fields
• Fla. Surgeon General Pushes To End State's Vaccine Mandates
• Weil, Cooley Lead Remedy Meds' $500M Thirty Madison Buy
• Judge Backs Harvard In Suit Over Trump's $2B Fund Freeze
• Novartis Inks Up To $5.2B Deal With Chinese Cardio Biotech
• Insurer Escapes Duty To Cover Lab's Suit Over COVID Tests
• Preparing For DEA Rescheduling Of 2 Research Chemicals
• Sports Doctor Group Can't Ditch $8.5M Patient Death Verdict
• NJ Health Biz Can't Move Data Privacy Suit To NY
• Arkansas Insurance Rule Beats Union Plan's ERISA Challenge
• BakerHostetler Adds King & Spalding Health Pro In Atlanta
• Wheeling & Appealing: The Latest Must-Know Appellate Action
• 5th Circ. Judge Says Reimbursement Drop 'Not Chicken Feed'
• 9th Circ. Rejects Unvaxxed Firefighters' Discrimination Appeal
• DOJ Accuses Nonprofit Nursing Home Chain Of FCA Violations
• $33M Pfizer Antitrust Deal OK'd, First MDL Trial Date Set
• Confusion Over Slashed Patent Verdict Vexes Fed. Circ. Judge
• Care Facility Not Covered In Patient Death Suits, Insurer Says
• CooperSurgical Says Earlier Cases Sink Conn. Filshie Clip Suits
• FDA's New Cigarette Warning Label Rule Tossed By Ga. Judge
• NC Court Upholds Ruling Against Pay For Pre-Job Training
• Pot Cos. Say Berkshire Hathaway Unit Must Cover Death Suit
• Defunding Planned Parenthood Is Meant To Punish, Judge Says
• Wells Fargo Employee Drug Cost Battle: What To Know
• Adapting To Private Practice: From Texas AUSA To BigLaw
• 'Never My Intention' To Defy Justices, Judge In NIH Case Says
• HHS Office Of Inspector General Leader Joins Arnold & Porter
• Evernorth Health Plugs $3.5B Into Shields Health Solutions